Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Revenue (2019 - 2025)

Historic Revenue for Cyclerion Therapeutics (CYCN) over the last 6 years, with Q3 2025 value amounting to $875000.0.

  • Cyclerion Therapeutics' Revenue rose 35103.09% to $875000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 137164.95%. This contributed to the annual value of $2.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Cyclerion Therapeutics' Revenue is $875000.0, which was up 35103.09% from $93000.0 recorded in Q2 2025.
  • Cyclerion Therapeutics' 5-year Revenue high stood at $3.0 million for Q2 2021, and its period low was $62000.0 during Q1 2021.
  • In the last 4 years, Cyclerion Therapeutics' Revenue had a median value of $348000.0 in 2021 and averaged $728090.9.
  • As far as peak fluctuations go, Cyclerion Therapeutics' Revenue tumbled by 9388.56% in 2021, and later surged by 104677.42% in 2022.
  • Cyclerion Therapeutics' Revenue (Quarter) stood at $533000.0 in 2021, then crashed by 42.59% to $306000.0 in 2022, then soared by 490.2% to $1.8 million in 2024, then tumbled by 51.55% to $875000.0 in 2025.
  • Its Revenue stands at $875000.0 for Q3 2025, versus $93000.0 for Q2 2025 and $81000.0 for Q1 2025.